Diabetic Retinopathy

"Diabetic Retinopathy" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Disease of the RETINA as a complication of DIABETES MELLITUS. It is characterized by the progressive microvascular complications, such as ANEURYSM, interretinal EDEMA, and intraocular PATHOLOGIC NEOVASCULARIZATION.

Descriptor ID	D003930
MeSH Number(s)	C11.768.257 C14.907.320.382 C19.246.099.500.382
Concept/Terms	Diabetic Retinopathy Diabetic Retinopathy Diabetic Retinopathies Retinopathies, Diabetic Retinopathy, Diabetic

Below are MeSH descriptors whose meaning is more general than "Diabetic Retinopathy".

Diseases [C]
Eye Diseases [C11]
Retinal Diseases [C11.768]
Diabetic Retinopathy [C11.768.257]
Cardiovascular Diseases [C14]
Vascular Diseases [C14.907]
Diabetic Angiopathies [C14.907.320]
Diabetic Retinopathy [C14.907.320.382]
Endocrine System Diseases [C19]
Diabetes Mellitus [C19.246]
Diabetes Complications [C19.246.099]
Diabetic Angiopathies [C19.246.099.500]
Diabetic Retinopathy [C19.246.099.500.382]

Below are MeSH descriptors whose meaning is more specific than "Diabetic Retinopathy".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Diabetic Retinopathy" by people in this website by year, and whether "Diabetic Retinopathy" was a major or minor topic of these publications.

Bar chart showing 139 publications over 29 distinct years, with a maximum of 16 publications in 2023

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1996	1	0	1
1998	1	0	1
1999	3	0	3
2000	1	0	1
2001	1	0	1
2002	2	0	2
2003	1	2	3
2004	1	0	1
2005	3	1	4
2006	1	2	3
2007	1	0	1
2008	0	1	1
2009	1	1	2
2010	3	0	3
2011	1	2	3
2012	1	0	1
2013	1	0	1
2014	4	0	4
2015	9	1	10
2016	2	1	3
2017	2	1	3
2018	12	2	14
2019	5	0	5
2020	12	1	13
2021	13	1	14
2022	9	0	9
2023	16	0	16
2024	14	0	14
2025	2	0	2

Below are the most recent publications written about "Diabetic Retinopathy" by people in Profiles.

Magrath G, Luvisi J, Russakoff D, Oakley J, Say EA, Blice J, Jayagopal A, Tucker S, Loayza A, Baker GH, Obeid JS. Use of a Convolutional Neural Network to Predict the Response of Diabetic Macular Edema to Intravitreal Anti-VEGF Treatment: A Pilot Study. Am J Ophthalmol. 2025 May; 273:176-181.

View in: PubMed
Kalavar M, Sridhar J. Clinical trials and real-world studies examining faricimab and high-dose aflibercept for wet age-related macular degeneration and diabetic macular edema. Curr Opin Ophthalmol. 2025 May 01; 36(3):189-198.

View in: PubMed
Alsoudi AF, Wai KM, Koo E, Parikh R, Mruthyunjaya P, Rahimy E. Initial Therapy of Panretinal Photocoagulation vs Anti-VEGF Injection for Proliferative Diabetic Retinopathy. JAMA Ophthalmol. 2024 10 01; 142(10):972-975.

View in: PubMed
Rohowetz LJ, Shaheen A, Magraner M, Flynn HW, Williams BK, Smiddy WE, Sridhar J, Russell JF, Townsend JH, Berrocal AM, Albini T, Yannuzzi NA. SURGICAL OUTCOMES IN CONCURRENT SICKLE CELL AND DIABETIC RETINOPATHY. Retina. 2024 09 01; 44(9):1560-1564.

View in: PubMed
Durrani AF, Momenaei B, Wakabayashi T, Vemula S, Pandit SA, Hsu J, Ho AC, Spirn MJ, Klufas MA, Garg SJ, Vander JF, Regillo CD, Chiang A, Kuriyan AE, Yonekawa Y. Conversion to faricimab after prior anti-vascular endothelial growth factor therapy for persistent diabetic macular oedema. Br J Ophthalmol. 2024 08 22; 108(9):1257-1262.

View in: PubMed
Rahimy E, Koo EB, Wai KM, Ludwig CA, Kossler AL, Mruthyunjaya P. Impact of Obstructive Sleep Apnea on Diabetic Retinopathy Progression and Systemic Complications. Am J Ophthalmol. 2025 02; 270:93-102.

View in: PubMed
Shah S, Chou B, Patel M, Watane A, Shah L, Yannuzzi N, Sridhar J. Review and analysis of history and utilization of panretinal photocoagulation and ranibizumab after publication of protocol S. Curr Opin Ophthalmol. 2024 Sep 01; 35(5):369-375.

View in: PubMed
Alsoudi AF, Wai KM, Koo E, Parikh R, Mruthyunjaya P, Rahimy E. Progression to Pars Plana Vitrectomy in Patients With Proliferative Diabetic Retinopathy. JAMA Ophthalmol. 2024 07 01; 142(7):662-668.

View in: PubMed
Moshfeghi AA, Khurana RN, Moini H, Sherman S, Reed K, Boucher N, Rahimy E. Impact of anti-VEGF treatment on development of proliferative diabetic retinopathy in routine clinical practice. BMC Ophthalmol. 2024 May 31; 24(1):229.

View in: PubMed
Cappellani F, Regillo CD, Haller JA, Gagliano C, Pulido JS. Exploring the Associated Genetic Causes of Diabetic Retinopathy as a Model of Inflammation in Retinal Diseases. Int J Mol Sci. 2024 May 17; 25(10).

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement